Variant report

Variant	esv3408115
Chromosome Location	chr9:975477-978825
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:86)
CpG islands
(count:794)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:86 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:976333-976475	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD1	chr9:976980-977174	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD1	chr9:977536-977736	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD2	chr9:976157-976788	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr9:977073-977522	H1-hESC	embryonic stem cell:	n/a	n/a
6	CREB1	chr9:976948-977400	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTBP2	chr9:974518-975511	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr9:975752-978187	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr9:976372-976503	HepG2	liver:	n/a	n/a
10	CTCF	chr9:976407-976537	A549	lung:	n/a	n/a
11	CTCF	chr9:976979-977179	GM12878	blood:	n/a	n/a
12	CTCF	chr9:977141-977291	MCF-7	breast:	n/a	n/a
13	CTCF	chr9:976400-976550	WERI-Rb-1	eye:	n/a	n/a
14	CTCF	chr9:976380-976530	GM12866	blood:	n/a	n/a
15	CTCF	chr9:977160-977310	WERI-Rb-1	eye:	n/a	n/a
16	CTCF	chr9:977145-977252	MCF-7	breast:	n/a	n/a
17	CTCF	chr9:976400-976550	GM12874	blood:	n/a	n/a
18	CTCF	chr9:976960-977078	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr9:977120-977270	SAEC	small airway:	n/a	n/a
20	CTCF	chr9:976400-976550	HRE	kidney:	n/a	n/a
21	CTCF	chr9:977141-977260	NHEK	skin:	n/a	n/a
22	CTCF	chr9:976991-977075	A549	lung:	n/a	n/a
23	CTCF	chr9:976300-976450	SAEC	small airway:	n/a	n/a
24	CTCF	chr9:977151-977252	LNCaP	prostate:	n/a	n/a
25	CTCF	chr9:976378-976556	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr9:976420-976570	GM12869	blood:	n/a	n/a
27	CTCF	chr9:976300-976450	HRE	kidney:	n/a	n/a
28	CTCF	chr9:976316-976562	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr9:976400-976550	HEK293	kidney:	n/a	n/a
30	CTCF	chr9:977169-977237	MCF-7	breast:	n/a	n/a
31	CTCF	chr9:976260-976410	GM06990	blood:	n/a	n/a
32	CTCF	chr9:976380-976530	GM06990	blood:	n/a	n/a
33	CTCF	chr9:976905-977045	HepG2	liver:	n/a	n/a
34	CTCF	chr9:977142-977276	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr9:977320-977470	GM12866	blood:	n/a	n/a
36	CTCF	chr9:976760-976910	WERI-Rb-1	eye:	n/a	n/a
37	CTCF	chr9:977060-977210	GM12874	blood:	n/a	n/a
38	CTCF	chr9:977129-977302	MCF-7	breast:	n/a	n/a
39	CTCF	chr9:977191-977275	Fibrobl	skin:	n/a	n/a
40	CTCF	chr9:976360-976510	HEK293	kidney:	n/a	n/a
41	CTCF	chr9:977134-977224	A549	lung:	n/a	n/a
42	CTCF	chr9:977100-977250	SAEC	small airway:	n/a	n/a
43	CTCF	chr9:976980-977130	GM12878	blood:	n/a	n/a
44	CTCF	chr9:977115-977322	MCF-7	breast:	n/a	n/a
45	CTCF	chr9:977140-977290	HEK293	kidney:	n/a	n/a
46	E2F6	chr9:976450-977341	H1-hESC	embryonic stem cell:	n/a	chr9:976702-976712
47	E2F6	chr9:976591-977334	H1-hESC	embryonic stem cell:	n/a	chr9:976702-976712
48	EGR1	chr9:976081-976571	H1-hESC	embryonic stem cell:	n/a	n/a
49	EGR1	chr9:976631-977630	H1-hESC	embryonic stem cell:	n/a	chr9:976990-977000 chr9:977491-977501
50	GABPA	chr9:976605-976939	H1-hESC	embryonic stem cell:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:976947-976997	HUVEC	blood vessel:	n/a
2	chr9:976947-976997	HUVEC	blood vessel:	n/a
3	chr9:977490-977540	AG04450	lung:	fetal
4	chr9:976638-976688	MCF10A-Er-Src	breast:	n/a
5	chr9:978258-978308	GM19239	blood:	n/a
6	chr9:977490-977540	ovcar-3	ovarian:	n/a
7	chr9:975997-976047	HCPEpiC	choroid plexus:	n/a
8	chr9:975997-976047	HMEC	breast:	n/a
9	chr9:977109-977159	CMK	blood:	n/a
10	chr9:977770-977820	HCF	heart:	n/a
11	chr9:977556-977606	NHDF-neo	bronchial:	n/a
12	chr9:975997-976047	ovcar-3	ovarian:	n/a
13	chr9:977556-977606	MCF10A-Er-Src	breast:	n/a
14	chr9:975997-976047	CMK	blood:	n/a
15	chr9:978258-978308	HAEpiC	amniotic membrane:	n/a
16	chr9:976638-976688	ProgFib	skin:	n/a
17	chr9:975856-975906	Hela-S3	cervix:	n/a
18	chr9:976634-976684	PFSK-1	brain:	n/a
19	chr9:977818-977868	LNCaP	prostate:	n/a
20	chr9:976645-976695	LNCaP	prostate:	n/a
21	chr9:977109-977159	T-47D	breast:	n/a
22	chr9:975856-975906	Hepatocyte	liver:	n/a
23	chr9:975856-975906	AG10803	skin:	n/a
24	chr9:976947-976997	AG10803	skin:	n/a
25	chr9:977556-977606	HAEpiC	amniotic membrane:	n/a
26	chr9:978258-978308	CMK	blood:	n/a
27	chr9:977770-977820	BE2_C	brain:	n/a
28	chr9:975856-975906	HCT-116	colon:	n/a
29	chr9:975997-976047	A549	lung:	n/a
30	chr9:975825-975875	A549	lung:	n/a
31	chr9:976645-976695	Jurkat	blood:	n/a
32	chr9:976634-976684	AoSMC	blood vessel:	n/a
33	chr9:977490-977540	SAEC	small airway:	n/a
34	chr9:975856-975906	PANC-1	pancreas:	n/a
35	chr9:977770-977820	ProgFib	skin:	n/a
36	chr9:976638-976688	GM06990	blood:	n/a
37	chr9:978258-978308	AG04450	lung:	fetal
38	chr9:976947-976997	GM12878	blood:	n/a
39	chr9:977109-977159	HRCEpiC	kidney:	n/a
40	chr9:975997-976047	HEK293	kidney:	embryo
41	chr9:977770-977820	SKMC	muscle:	n/a
42	chr9:976947-976997	HMEC	breast:	n/a
43	chr9:977109-977159	HNPCEpiC	eye:	n/a
44	chr9:976634-976684	Hepatocyte	liver:	n/a
45	chr9:975856-975906	H1-hESC	embryonic stem cell:	embryo
46	chr9:977490-977540	HRCEpiC	kidney:	n/a
47	chr9:975997-976047	AG09309	skin:	n/a
48	chr9:977770-977820	GM12892	blood:	n/a
49	chr9:975825-975875	GM12892	blood:	n/a
50	chr9:977490-977540	CMK	blood:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:978343..980542-chr9:980897..983519,2	K562	blood:
2	chr9:970488..973347-chr9:974585..976403,2	K562	blood:

No data

Variant related genes	Relation type
DMRT3	TF binding region
DMRT3	CpG island

Extended variants
information (count: 150 )
Associated
traits (count: 109 )

Variant overlapped rSNPs/rCNVs (count:150 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs202132103	chr9:975484-975485	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs540881098	chr9:975503-975504	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs535669610	chr9:975507-975508	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs140807044	chr9:975532-975533	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs568976183	chr9:975544-975545	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs537959272	chr9:975556-975557	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs557683838	chr9:975560-975561	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs72701085	chr9:975568-975569	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs571118486	chr9:975573-975574	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs72701088	chr9:975604-975605	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs575999162	chr9:975611-975612	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs149749071	chr9:975617-975618	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs539548471	chr9:975641-975642	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs574272910	chr9:975658-975659	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs543208035	chr9:975659-975660	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs556802120	chr9:975680-975681	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs371366189	chr9:975708-975709	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs575361421	chr9:975724-975725	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs145601018	chr9:975744-975745	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs563919646	chr9:975783-975784	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs10977919	chr9:975788-975789	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs561245584	chr9:975837-975838	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs3812518	chr9:975880-975881	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs140381570	chr9:975901-975902	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs180754851	chr9:975971-975972	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs555274194	chr9:976032-976033	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs75099881	chr9:976035-976036	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs112213190	chr9:976055-976056	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs137878240	chr9:976080-976081	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs531689004	chr9:976146-976147	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs551494199	chr9:976152-976153	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs571528114	chr9:976224-976225	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs376904694	chr9:976253-976254	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs540801583	chr9:976338-976339	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs534166891	chr9:976350-976351	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs553893446	chr9:976356-976357	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs567905969	chr9:976359-976360	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs536946653	chr9:976372-976373	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs556789583	chr9:976375-976376	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs576747879	chr9:976388-976389	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs544311063	chr9:976390-976391	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs116788945	chr9:976407-976408	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs574318517	chr9:976415-976416	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs577687677	chr9:976420-976421	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs73639954	chr9:976434-976435	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs559903370	chr9:976435-976436	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs529106177	chr9:976448-976449	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs542561213	chr9:976467-976468	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs116573158	chr9:976532-976533	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs531430743	chr9:976552-976553	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:109)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	21272361	CNVD
Non-small cell lung cancer	16651412	CNVD
Ovarian cancer	21781307	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD

Chromatin state (count:204 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:973000-976200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
2	chr9:973200-976000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
3	chr9:974000-976000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
4	chr9:974400-977800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
5	chr9:974800-976000	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
6	chr9:974800-976000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
7	chr9:975000-975600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr9:975000-975800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
9	chr9:975200-976000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr9:975200-976800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
11	chr9:975400-975600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
12	chr9:975400-975800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
13	chr9:975400-975800	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr9:975400-975800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
15	chr9:975400-976200	Weak transcription	Pancreas	Pancrea
16	chr9:975400-976200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
17	chr9:975400-978800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
18	chr9:975600-975800	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr9:975600-975800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr9:975600-976000	Bivalent Enhancer	Adipose Nuclei	Adipose
21	chr9:975600-976000	Bivalent Enhancer	Colonic Mucosa	Colon
22	chr9:975600-976400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
23	chr9:975600-977400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr9:975800-976000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr9:975800-976000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
26	chr9:975800-976000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
27	chr9:975800-976200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
28	chr9:975800-976200	Bivalent Enhancer	Brain Germinal Matrix	brain
29	chr9:975800-976200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
30	chr9:975800-976600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr9:975800-977400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
32	chr9:976000-976200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr9:976000-976200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
34	chr9:976000-976200	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr9:976000-976200	Flanking Bivalent TSS/Enh	Fetal Brain Male	brain
36	chr9:976000-976200	Bivalent Enhancer	Fetal Lung	lung
37	chr9:976000-976200	Bivalent Enhancer	A549	lung
38	chr9:976000-976400	Bivalent Enhancer	Colon Smooth Muscle	Colon
39	chr9:976000-976400	Bivalent Enhancer	Fetal Heart	heart
40	chr9:976000-976600	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr9:976000-976600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
42	chr9:976000-976600	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
43	chr9:976000-976600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
44	chr9:976000-976600	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
45	chr9:976000-976600	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
46	chr9:976000-976800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr9:976000-977200	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
48	chr9:976000-977200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
49	chr9:976000-977200	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
50	chr9:976000-977600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links